Title: Early Phase Modelling – Estimating the Costs and Effectiveness of a Pharmaceutical before Clinical Trial
Duration: 55 minutes - Available On Demand
This webinar offers an overview of the benefits early-phase, health-economic modelling can provide, at a stage when the outcome of the product development program is still largely unknown. Early-Phase Modelling balances between accuracy and manageability, and represents an easy to grasp, conceptual overview of your product and its potentials regarding reimbursement.
Senior Manager, Health Economics & Outcomes Research
Åse Björstad is a licensed pharmacist, and holds a PhD in Medicine with special emphasis on leukocyte biology from the University of Gothenburg, Sweden. Following her doctoral thesis, she held a position as a lecturer at the faculty of Pharmacy and Pharmaceutical Sciences at the University of Umeå. In 2010, she was recruited to Nordic Health Economics (now PharmaLex) and has since then gained 9 years of experience from hands-on work and project management within health economics and real-world evidence studies.